A detailed history of First Foundation Advisors transactions in Pfizer Inc stock. As of the latest transaction made, First Foundation Advisors holds 202,937 shares of PFE stock, worth $5.43 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
202,937
Previous 174,692 16.17%
Holding current value
$5.43 Million
Previous $4.89 Million 20.16%
% of portfolio
0.23%
Previous 0.19%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $782,386 - $886,610
28,245 Added 16.17%
202,937 $5.87 Million
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $473,397 - $554,733
18,741 Added 12.02%
174,692 $4.89 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $535,146 - $614,519
20,670 Added 15.28%
155,951 $4.33 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $932,083 - $1.21 Million
-35,671 Reduced 20.87%
135,281 $3.89 Million
Q3 2023

Nov 15, 2023

BUY
$32.09 - $37.51 $334,217 - $390,666
10,415 Added 6.49%
170,952 $5.67 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $597,894 - $691,749
16,553 Added 11.5%
160,537 $5.89 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $69,523 - $90,509
1,765 Added 1.24%
143,984 $5.87 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $420,422 - $548,815
-10,070 Reduced 6.61%
142,219 $7.29 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $145,370 - $177,461
-3,322 Reduced 2.13%
152,289 $6.66 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $145,370 - $177,461
-3,322 Reduced 2.13%
152,289 $6.66 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $224,088 - $265,698
-4,816 Reduced 3.0%
155,611 $8.16 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $236,344 - $292,860
-5,166 Reduced 3.12%
160,427 $8.31 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $171,891 - $254,800
-4,160 Reduced 2.45%
165,593 $9.78 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $814,516 - $1.05 Million
-20,752 Reduced 10.89%
169,753 $7.3 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $15.5 Million - $17.6 Million
-431,754 Reduced 69.38%
190,505 $7.46 Million
Q1 2021

May 18, 2021

SELL
$33.49 - $37.77 $278,435 - $314,019
-8,314 Reduced 1.32%
622,259 $22.5 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $385,306 - $489,950
11,512 Added 1.86%
630,573 $23.2 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $945,038 - $1.11 Million
-29,765 Reduced 4.59%
619,061 $22.7 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $543,003 - $658,743
-18,028 Reduced 2.7%
648,826 $21.2 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $213,158 - $304,557
-7,886 Reduced 1.17%
666,854 $21.8 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $3.51 Million - $3.99 Million
-106,688 Reduced 13.65%
674,740 $26.4 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $537,579 - $697,082
16,546 Added 2.16%
781,428 $28.1 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $402,379 - $451,779
-10,881 Reduced 1.4%
764,882 $33.1 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $1.47 Million - $1.61 Million
-39,108 Reduced 4.8%
775,763 $32.9 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1.2 Million - $1.37 Million
-31,296 Reduced 3.7%
814,871 $35.6 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $1.01 Million - $1.22 Million
-29,167 Reduced 3.33%
846,167 $37.3 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $3.98 Million - $4.24 Million
-120,573 Reduced 12.11%
875,334 $31.8 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $137,436 - $159,445
-4,307 Reduced 0.43%
995,907 $35.3 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $484,997 - $514,598
14,582 Added 1.48%
1,000,214 $36.2 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $15.7 Million - $17.3 Million
-506,230 Reduced 33.93%
985,632 $35.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,491,862
1,491,862 $50.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.